EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · IEX Real-Time Price · USD
7.35
+0.25 (3.52%)
Mar 28, 2024, 4:30 PM EDT - Market closed
EDAP TMS Market Cap
EDAP TMS has a market cap or net worth of $270.12 million as of March 28, 2024. Its market cap has decreased by -27.58% in one year.
Market Cap
270.12M
Enterprise Value
229.46M
1-Year Change
-27.58%
Ranking
Category
Stock Price
$7.35
Market Cap Chart
Since December 31, 2001, EDAP TMS's market cap has increased from $17.50M to $270.12M, an increase of 1,443.57%. That is a compound annual growth rate of 13.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 272.40M | 3.50% |
Mar 27, 2024 | 263.20M | -2.59% |
Mar 26, 2024 | 270.20M | -1.35% |
Mar 25, 2024 | 273.90M | -0.04% |
Mar 22, 2024 | 274.00M | 0.04% |
Mar 21, 2024 | 273.90M | -1.83% |
Mar 20, 2024 | 279.00M | -0.14% |
Mar 19, 2024 | 279.40M | 3.98% |
Mar 18, 2024 | 268.70M | -3.21% |
Mar 15, 2024 | 277.60M | 1.80% |
Mar 14, 2024 | 272.70M | -2.19% |
Mar 13, 2024 | 278.80M | 1.27% |
Mar 12, 2024 | 275.30M | 0.66% |
Mar 11, 2024 | 273.50M | -1.48% |
Mar 8, 2024 | 277.60M | -0.25% |
Mar 7, 2024 | 278.30M | -1.45% |
Mar 6, 2024 | 282.40M | -1.91% |
Mar 5, 2024 | 287.90M | 2.35% |
Mar 4, 2024 | 281.30M | 11.80% |
Mar 1, 2024 | 251.60M | 7.57% |
Feb 29, 2024 | 233.90M | 9.71% |
Feb 28, 2024 | 213.20M | -2.87% |
Feb 27, 2024 | 219.50M | 0.87% |
Feb 26, 2024 | 217.60M | -2.16% |
Feb 23, 2024 | 222.40M | -0.58% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Xeris Biopharma Holdings | 287.93M |
Gossamer Bio | 277.47M |
Atai Life Sciences | 275.58M |
Inotiv | 274.67M |
Compass Therapeutics | 271.55M |
Poseida Therapeutics | 271.13M |
Coherus BioSciences | 271.08M |
Puma Biotechnology | 269.96M |